Scott A. Kendrick

Nephrology

511 Paladin Dr
Greenville, NC 27834

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Early outcomes associated with de novo once-daily extended-release versus twice-daily immediate-release tacrolimus in a predominantly African American kidney transplant population: A single-center observational study.

Early outcomes associated with de novo once-daily extended-release versus twice-daily immediate-release tacrolimus in a predominantly African American kidney transplant population: A single-center observational study.

Journal: Clinical transplantation

Published: September 14, 2023

Racial differences in incident de novo donor-specific anti-HLA antibody among primary renal allograft recipients: results from a single center cohort study.

Racial differences in incident de novo donor-specific anti-HLA antibody among primary renal allograft recipients: results from a single center cohort study.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: October 16, 2016

Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.

Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: September 15, 2015

Changes in successive measures of de novo donor-specific anti-human leukocyte antigen antibodies intensity and the development of allograft dysfunction.

Changes in successive measures of de novo donor-specific anti-human leukocyte antigen antibodies intensity and the development of allograft dysfunction.

Journal: Transplantation

Published: June 10, 2014

Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients.

Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients.

Journal: Transplantation

Published: February 04, 2014

Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation.

Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation.

Journal: Clinical transplants

Published: January 01, 2014

Trends and characteristics in early glomerular filtration rate decline after posttransplantation alloantibody appearance.

Trends and characteristics in early glomerular filtration rate decline after posttransplantation alloantibody appearance.

Journal: Transplantation

Published: August 06, 2013

The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.

The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.

Journal: Transplantation

Published: March 22, 2013

Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.

Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.

Journal: Transplantation

Published: February 06, 2013

Novel biomarker combination predicts long-term allograft outcome.

Novel biomarker combination predicts long-term allograft outcome.

Journal: Clinical transplants

Published: January 01, 2013

Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.

Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 10, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026